- CA$39.06m
- CA$39.07m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.79 | 4.6 | 3.12 | 3.84 | 12.6 |
Operating Profit | -7.79 | -4.6 | -3.12 | -3.84 | -12.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.71 | -5.97 | -4.74 | -4.73 | -12.5 |
Net Income After Taxes | -7.71 | -5.97 | -4.74 | -4.73 | -12.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.71 | -5.97 | -4.74 | -4.73 | -12.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.71 | -5.97 | -4.74 | -4.73 | -12.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.12 | -0.081 | -0.052 | -0.102 | -0.11 |